City of Hope receives $4.9M for stem cell training program

How we improved the treatment of Hodgkin lymphoma

Hodgkin lymphoma has long been a model disease in the field of oncology—one of the first diseases we learned to cure with radiation and ultimately chemotherapy.

RAS-mutant leukemia stem cells behave differently from other leukemia stem cells

Research from the Icahn School of Medicine at Mount Sinai provides new insights into acute myeloid leukemia and its resistance to a common treatment. The study, published Oct. 30 in Nature, was led by Eirini Papapetrou, professor of oncological sciences at Icahn Mount Sinai. Acute myeloid leukemia is a devastating blood cancer that starts in...

November 08, 2024

Vol.50 No.42

In Brief

Longevity Consortium receives $45M grant

The Longevity Consortium received a five-year, $45 million grant to move the consortium’s work to its next stage: integrating results from numerous studies about the factors that contribute to longer and healthier lives.

November 01, 2024

Vol.50 No.41

In Brief

Robert Jenq named director of microbiome program at City of Hope

Robert R. Jenq was named director of the microbiome program at City of Hope and clinical professor in the Department of Hematology and Hematopoietic Cell Transplantation.

September 20, 2024

Vol.50 No.35

Conversation with The Cancer Letter

A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease

City of Hope has received a $150 million gift from entrepreneurs and philanthropists A. Emmet Stephenson Jr. and his daughter Tessa Stephenson Brand to create a program focused on pancreatic cancer research.

September 17, 2024

Vol.50 No.35

By Paul Goldberg